Search Count: 9
 |
Structure Of Sars-Cov2 Plpro Bound To A Covalent Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2023-04-05 Classification: HYDROLASE/INHIBITOR Ligands: WUK, ZN, SO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-04-05
Ligands: WUK, ZN, SO4
 |
Crystal Structure Of Sars-Cov-2 Main Protease (3Clpro/Mpro) In Complex With Covalent Inhibitor Leupeptin
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.32 Å Release Date: 2021-05-19 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: DMS |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2021-05-19
Ligands: DMS
 |
Crystal Structure Of Sars-Cov-2 Main Protease (3Clpro/Mpro) In Complex With Covalent Inhibitor Vby-825 (Partial Occupancy)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2021-05-12 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: ZL7, DMS |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-05-12
Ligands: ZL7, DMS
 |
Room-Temperature X-Ray Structure Of Sars-Cov-2 Main Protease (3Cl Mpro) In Complex With A Non-Covalent Inhibitor Mcule-5948770040
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2021-03-03 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: YD1 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-03-03
Ligands: YD1
 |
Sars-Cov-2 Main Protease Co-Crystal Structure With Telaprevir Determined From Crystals Grown With 40 Nl Acoustically Ejected Mpro Droplets At 1.48 A Resolution (Cryo-Protected)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2020-09-30 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: DMS, SV6 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-09-30
Ligands: DMS, SV6
 |
Sars-Cov-2 Main Protease Co-Crystal Structure With Telaprevir Determined From Crystals Grown With 40 Nl Acoustically Ejected Mpro Droplets At 1.63 A Resolution (Direct Vitrification)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2020-09-30 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: DMS, SV6 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-09-30
Ligands: DMS, SV6
 |
Crystal Structure Of Sars-Cov-2 Main Protease (3Clpro/Mpro) At 1.2 A Resolution And A Possible Capture Of Zinc Binding Intermediate
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.20 Å Release Date: 2020-09-23 Classification: VIRAL PROTEIN, HYDROLASE Ligands: DMS, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-09-23
Ligands: DMS, ZN
 |
Crystal Structure Of Sars-Cov-2 Main Protease (3Clpro/Mpro) In Complex With Covalent Inhibitor Boceprevir At 1.35 A Resolution
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.35 Å Release Date: 2020-09-23 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: U5G, DMS |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-09-23
Ligands: U5G, DMS
 |
Crystal Structure Of Sars-Cov-2 Main Protease (3Clpro/Mpro) In Complex With Covalent Inhibitor Narlaprevir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2020-09-09 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: NNA, DMS, NA |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-09-09
Ligands: NNA, DMS, NA